trifluridine / tipiracil

Lonsurf®

Pages intended for UK practising Healthcare Professionals only

Therapeutic indications1

Lonsurf is indicated for the treatment of adult patients with metastatic colorectal cancer (CRC) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents.

New Treatment for Patients with Refractory Metastatic Colorectal Cancer:

SPC

PIL

PI

 

1. Lonsurf Summary of Product Characteristics

 

UK16WEB0004(1) DoP: September 2017